Datametrex AI Ltd V.DM

Alternate Symbol(s): DTMXF

Technology Information Technology Services

Datametrex AI Limited is a technology-focused company with exposure to artificial intelligence, healthcare, and mobile gaming. It is focused on collecting, analyzing and presenting structured and unstructured data using machine learning and artificial intelligence. The Company's products include AnalyticsGPT, Cyber Security, and Healthcare. AnalyticsGPT platform scans vast data streams from social media, news, blogs, forums, messengers, enterprise data, and the dark Web, creating predictive analytics. Cyber Security is a deep analytics platform that captures, structures, and visualizes vast amounts of unstructured social media data, which is used as a discovery tool that allows organizations to make decisions. It offers Nexa Products, which consists of NexaSecurity and NexaSMART. Healthcare consists of Imagine Health Centres, a multidisciplinary healthcare facility, and Medi-Call, a telehealth platform. The Company also offers a mobile blockchain game, Cereal Crunch.

TSXV:DM - Post by User

Datametrex AI Ltd > Awesome DM News Release

<< Previous

Bullboard Posts

Next >>

Comment by Resilience19on Apr 20, 2021 6:26am

174 Views

Post# 33027431

RE:RE:Awesome DM News Release

@yeehaw, at this point, given that no one, other than management, really have the answer to this, my take is that we're better off waiting Q4 s, which are only a week away, rather than pull numbers out of thin air. Either way, we should see a nice uptick in sp starting next week and leading into May's Q1 results.

Yeehaw1 wrote:
Excellent

but does it mean that for the month of march only DM profit if it's $50 per test kit then its $200k only

If Consider the somewhat same for January and February then total would be k600 roughly

anyone with different idea?

Mario79 wrote:

by @newsfile on 20 Apr 2021, 03:00

Datametrex Completes over 30,000 COVID-19 Tests and Sold over 40,000 Test Kits in March

Toronto, Ontario--(Newsfile Corp. - April 20, 2021) - Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTCQB: DTMXF) (the "Company" or "Datametrex") is pleased to announce that the Company completed over 30,000 PCR tests for the Film and Production industry in Toronto, Vancouver, and Montreal, and sold over 40,000 1 Copy PCR test kits during March.

The manufacturer has confirmed that these tests can detect the new variants which is key as we navigate the ongoing third wave that is spreading at a rapid pace in Canada.

"The company is pleased to see an increase in revenue in the COVID-19 business. With the new Brazil and UK variants spreading, management feels that continued testing will be necessary for the foreseeable future as part of the answer to keep people safe and sound," said Marshall Gunter, Chief Executive Officer of the Company.

About Datametrex

Datametrex AI Limited is a technology-focused company with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex's mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, Company provides progressive solutions to support the supply chain.

For additional information on Datametrex and other corporate information, please visit the Company's website at www.datametrex.com .

For further information, please contact:

Marshall Gunter - CEO
Phone: (514) 295-2300
Email: mgunter@datametrex.com

Neither the TSX Venture Exchange nor it's Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.